⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for recurrent childhood central nervous system embryonal tumor

Every month we try and update this database with for recurrent childhood central nervous system embryonal tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to TreatmentNCT00929903
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Metastatic Chil...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Unspecified Chi...
pazopanib hydro...
pharmacological...
2 Years - 25 YearsNational Cancer Institute (NCI)
Sunitinib in Treating Young Patients With Refractory Solid TumorsNCT00387920
Central Nervous...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Recurrent Child...
Unspecified Chi...
sunitinib malat...
pharmacological...
dynamic contras...
laboratory biom...
2 Years - 21 YearsNational Cancer Institute (NCI)
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System TumorsNCT01158300
Brain and Centr...
VEGF inhibitor ...
3 Years - 21 YearsPediatric Brain Tumor Consortium
Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell TumorsNCT00047320
Brain Tumor
Central Nervous...
Childhood Germ ...
carboplatin
etoposide
ifosfamide
thiotepa
adjuvant therap...
conventional su...
neoadjuvant the...
peripheral bloo...
radiation thera...
3 Years - 24 YearsChildren's Oncology Group
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to TreatmentNCT00929903
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Metastatic Chil...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Unspecified Chi...
pazopanib hydro...
pharmacological...
2 Years - 25 YearsNational Cancer Institute (NCI)
Combination Chemotherapy in Treating Young Patients With Advanced Solid TumorsNCT00281944
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Recurrent Child...
Recurrent Child...
Unspecified Chi...
oxaliplatin
fluorouracil
leucovorin calc...
pharmacological...
positron emissi...
computed tomogr...
- 21 YearsNational Cancer Institute (NCI)
Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain TumorsNCT00238173
Bone Marrow Sup...
Brain and Centr...
Drug/Agent Toxi...
Long-term Effec...
filgrastim
acetylcysteine
carboplatin
cyclophosphamid...
etoposide phosp...
mannitol
sodium thiosulf...
1 Year - 18 YearsOHSU Knight Cancer Institute
Combination Chemotherapy in Treating Young Patients With Advanced Solid TumorsNCT00281944
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Childhood Centr...
Recurrent Child...
Recurrent Child...
Unspecified Chi...
oxaliplatin
fluorouracil
leucovorin calc...
pharmacological...
positron emissi...
computed tomogr...
- 21 YearsNational Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: